Concepedia

Sam Hofmans

SH

Statistics

Publications

5

Citations

507

H-Index

5

Active since

2015

Affiliations

University of Antwerp(Current)

Ghent University

VIB-UGent Center for Inflammation Research

VIB-UGent Center for Medical Biotechnology

Sam Hofmans is an author at University of Antwerp specializing in medicinal chemistry, pharmacology, and necroptotic signaling.

ORCID

Publications per year

2015–2018

5

Publications

5

Discovery of Novel, Drug-Like Ferroptosis Inhibitors with in Vivo Efficacy

Lars Devisscher, Samya Van Coillie, Sam Hofmans et al. · Journal of Medicinal Chemistry · 2018 · 172 citations

, , +13

Novel Ferroptosis Inhibitors with Improved Potency and ADME Properties

Sam Hofmans, Tom Vanden Berghe, Lars Devisscher et al. · Journal of Medicinal Chemistry · 2015 · 137 citations

, , +15

Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury

Sofie Martens, Manhyung Jeong, Wulf Tonnus et al. · Cell Death and Disease · 2017 · 87 citations · Full text

, , +16

RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)

Sofie Martens, Vera Goossens, Lars Devisscher et al. · Cell Death and Disease · 2018 · 62 citations · Full text

, , +14

Tozasertib Analogues as Inhibitors of Necroptotic Cell Death

Sam Hofmans, Lars Devisscher, Sofie Martens et al. · Journal of Medicinal Chemistry · 2018 · 49 citations · Full text

, , +17

1–5 of 5